Artelo Biosciences, Inc. (ARTL)
$3.26-3.26%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Beta
- -0.07
- P/E (TTM)
- -0.05
- Short % float
- 2.12%
- Days to cover
- 1.0
- SI change
- +104.7%
- 1W
- -11.41%
- 1M
- -42.10%
- vs SPY 1W
- -12.57%
- vs SPY 1M
- -45.09%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ARTL?
- LOPJLB’s latest quantitative signal on Artelo Biosciences, Inc. (ARTL) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ARTL in?
- Artelo Biosciences, Inc. (ARTL) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Artelo Biosciences, Inc. (ARTL) do?
- Artelo Biosciences, Inc. functions as a clinical-stage biopharmaceutical enterprise dedicated to discovering and advancing therapies that modulate the endocannabinoid system. The company's robust developmental portfolio encompasses several promising candidates: ART27.13, a synthetic G protein-coupled receptor agonist currently undergoing Phase 1b/2a clinical investigation for cancer-related ano…